Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The main research objective is to work out the optimal doses of the novel combination of gemcitabine, oxaliplatin and imatinib mesylate (glivec) in patients with advanced pancreatic cancer that has progressed during or after treatment with first-line gemcitabine.
Inclusion criteria
- Advanced Pancreatic Cancer